Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma

Protein-protein Interaction Network Analyses for Elucidating the Roles of LOXL2-delta72 in Esophageal Squamous Cell Carcinoma

(2014) Bing-Li Wu et al.   Asian Pacific Journal of Cancer Prevention

LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition

(2014) E. P. Cuevas et al.   Biology Open

MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasivein Vitro

(2013) Hee-Jung Moon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling

(2013) H. E. Barker et al.   MOLECULAR CANCER RESEARCH

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell proliferation, migration and invasionin vitroand tumor growth in nude mice

(2012) Tiantian Zhang et al.   LEUKEMIA & LYMPHOMA

RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3

(2012) Nicolás Herranz et al.   MOLECULAR CELL

LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution

(2011) H. E. Barker et al.   CANCER RESEARCH

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

(2011) Gema Moreno-Bueno et al.   EMBO Molecular Medicine

Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase–like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma

(2011) Tian-Yu Li et al.   HUMAN PATHOLOGY

Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling

(2011) Alexander Herner et al.   INTERNATIONAL JOURNAL OF CANCER

The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation

(2011) Jennie Lugassy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer

(2011) Ann-Marie Baker et al.   JNCI-Journal of the National Cancer Institute

Involvement of CYR61 and CTGF in the Fascin-Mediated Proliferation and Invasiveness of Esophageal Squamous Cell Carcinomas Cells

(2010) Jian-Jun Xie et al.   AMERICAN JOURNAL OF PATHOLOGY

Ligand docking and binding site analysis with PyMOL and Autodock/Vina

(2010) Daniel Seeliger et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

(2010) Vivian Barry-Hamilton et al.   NATURE MEDICINE

Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

(2009) Janine T. Erler et al.   CANCER CELL

Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway

(2009) Liang Peng et al.   CARCINOGENESIS

Sp1 and AP-1 Regulate Expression of the Human GeneVIL2in Esophageal Carcinoma Cells

(2009) Shu-Ying Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes

(2009) Eita Fujimoto et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling

(2008) Gyoo Taik Kwon et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY